Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
NGM Biopharmaceuticals Inc (DE:0IK)
FRANKFURT:0IK
RESEARCH TOOLSreports
NGM Biopharmaceuticals (0IK) Ownership - Who Owns NGM Biopharmaceuticals?
0 Followers
NGM Biopharmaceuticals (0IK) Ownership Overview
0.00% Insiders
0.00% Mutual Funds
37.11% Other Institutional Investors
62.89% Public Companies and
Individual Investors
The ownership structure of NGM Biopharmaceuticals (DE:0IK) stock is a mix of institutional, retail and individual investors. Approximately 37.11% of the company’s stock is owned by Institutional Investors, 0.00% is owned by Insiders and 62.89% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Nov 17, 2023 | Column Group Lp Director, >10% Owner | Bought | $15375 |
| Nov 17, 2023 | David V Goeddel Director, >10% Owner | Bought | $18184 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,211,077 | Institution | ― | 3,382,948 | |
| 32,352 | Institution | 0.00% | 49,499 | |
| 7,339 | Institution | ― | 11,229 | |
| 17,343 | Institution | ― | 26,535 | |
| 48,976 | Institution | ― | 74,933 | |
| 22,336 | Institution | ― | 34,174 | |
| 70,174 | Institution | ― | 107,366 | |
| 154,642 | Institution | ― | 236,602 | |
| 2,416,742 | Institution | ― | 3,697,615 | |
| 450,562 | Institution | ― | 689,360 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 7,339 | Institution | ― | 11,229 | |
| 17,343 | Institution | ― | 26,535 | |
| 48,976 | Institution | ― | 74,933 | |
| 22,336 | Institution | ― | 34,174 | |
| 70,174 | Institution | ― | 107,366 | |
| 154,642 | Institution | ― | 236,602 | |
| 2,416,742 | Institution | ― | 3,697,615 | |
| 450,562 | Institution | ― | 689,360 | |
| 188,430 | Institution | ― | 288,298 | |
| 9,121 | Institution | ― | 13,955 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns NGM Biopharmaceuticals Inc (DE:0IK)?
According to the latest TipRanks data, approximately 37.11% of the company's stock is held by institutional investors, 0.00% is held by insiders, and 62.89% is held by retail investors.
What percentage of NGM Biopharmaceuticals Inc (DE:0IK) stock is held by institutional investors?
According to the latest TipRanks data, approximately 37.11% of NGM Biopharmaceuticals Inc (DE:0IK) stock is held by institutional investors.
What percentage of NGM Biopharmaceuticals Inc (DE:0IK) stock is held by retail investors?
According to the latest TipRanks data, approximately 62.89% of NGM Biopharmaceuticals Inc (DE:0IK) stock is held by retail investors.
Who owns the most shares of NGM Biopharmaceuticals Inc (DE:0IK)?
Vanguard owns the most shares of NGM Biopharmaceuticals Inc (DE:0IK).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.